Investment analysts at Lifesci Capital assumed coverage on shares of Sionna Therapeutics (NASDAQ:SION – Get Free Report) in a research report issued to clients and investors on Tuesday,Benzinga reports. The firm set an “outperform” rating and a $60.00 price target on the stock. Lifesci Capital’s target price indicates a potential upside of 40.09% from the […]

Roth Capital assumed coverage on shares of American Bitcoin (NASDAQ:ABTC – Free Report) in a research note published on Wednesday morning, MarketBeat reports. The firm issued a buy rating and a $4.00 price objective on the stock. ABTC has been the topic of a number of other reports. Weiss Ratings reissued a “sell (d)” rating […]

Equities researchers at Oppenheimer assumed coverage on shares of Centessa Pharmaceuticals (NASDAQ:CNTA – Get Free Report) in a note issued to investors on Wednesday. The firm set an “outperform” rating and a $62.00 price target on the stock. Oppenheimer’s price objective suggests a potential upside of 116.78% from the company’s previous close. Several other research […]